| Name | Title | Contact Details |
|---|
Futrix is a Portland, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Kedalion Therapeutics is a clinical-stage, venture-funded ophthalmic drug company based in Menlo Park, CA. Kedalions AcuStream technology delivers topical drugs to the eye in a precise and accurate manner that enables comparable efficacy with an 80% reduction in dose compared to standard drops, and a significantly improved side effect profile along with patient comfort and convenience following self-administration.
Memorial Health System of East Texas, doing business as Memorial Medical Center of East Texas, operates not-for-profit hospitals in Lufkin, Livingston, and San Augustine. It offers diabetes, dialysis, emergency, homecare, lab imaging, intensive care, orthopedics, rehabilitation, robotic surgery, sexual assault nurse examiner, sleep lab, social, stroke, surgery, and wound care and hyperbaric oxygen services, as well as cancer, cardiovascular and stroke, infusion, ambulatory, and women’s and children’s center services. The company was founded in 1949 and is based in Lufkin, Texas.
Southern Scripts provides innovative and transformative pharmacy benefit management (PBM) solutions that guarantee employers complete flexibility and control over their benefit plan.
AstraZeneca is a global, science-led biopharmaceutical company that spans the discovery, development, manufacturing, distribution and worldwide commercialisation of primary care and speciality care medicines. We believe the best way we can help patients is to focus on breakthrough science in order to uncover disease mechanisms and develop novel, targeted therapies that interact with them. This is at the heart of our purpose as a company: to push the boundaries of science to deliver life-changing medicines. We invest in distinctive science in three main therapy areas where we believe we can make the most meaningful difference to patients: oncology; cardiovascular and metabolic diseases; and respiratory, inflammation and autoimmunity. Our science exploits our rare combination of capabilities in small molecules and biologics, immunotherapies, protein engineering technologies and devices. These are reinforced by a strong focus on translational science and personalised healthcare capabilities. We build on our own capabilities by collaborating with world-renowned scientists and academic institutions and partnering with like-minded science-led companies. Through leading in science, we are confident that we can transform the lives of people around the world and deliver value to our shareholders.